| 000 | 01839 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517193520.0 | ||
| 264 | 0 | _c20190924 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a2047-9980 | ||
| 024 | 7 |
_a10.1161/JAHA.117.007881 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGray, Matthew P | |
| 245 | 0 | 0 |
_aOutcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline. _h[electronic resource] |
| 260 |
_bJournal of the American Heart Association _c01 2018 |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdministrative Claims, Healthcare |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xdiagnosis |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aComparative Effectiveness Research |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuideline Adherence _xstandards |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedicare |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPractice Guidelines as Topic _xstandards |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstandards |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStroke _xdiagnosis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aSaba, Samir | |
| 700 | 1 | _aZhang, Yuting | |
| 700 | 1 | _aHernandez, Inmaculada | |
| 773 | 0 |
_tJournal of the American Heart Association _gvol. 7 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/JAHA.117.007881 _zAvailable from publisher's website |
| 999 |
_c27948577 _d27948577 |
||